Key takeaways
Clinical trials haven’t directly compared Ozempic vs. phentermine for weight loss, but Ozempic generally leads to more weight loss.
Phentermine is an older weight loss pill that’s typically used short-term, while Ozempic is a weekly injectable that’s prescribed for type 2 diabetes or off-label for weight loss.
Phentermine isn’t safe for everyone because it can affect blood pressure and heart health, among other risks. But the low cost of phentermine makes it a more affordable option, especially if your insurance doesn’t cover Ozempic.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
Clinical trials haven’t directly compared Ozempic vs. phentermine for weight loss, but Ozempic generally leads to more weight loss.
Phentermine is an older weight loss pill that’s typically used short-term, while Ozempic is a weekly injectable that’s prescribed for type 2 diabetes or off-label for weight loss.
Phentermine isn’t safe for everyone because it can affect blood pressure and heart health, among other risks. But the low cost of phentermine makes it a more affordable option, especially if your insurance doesn’t cover Ozempic.
Phentermine is approved by the US Food and Drug Administration (FDA) for weight management. While Ozempic is not FDA-approved for weight loss, it can be used off-label for weight loss.
Studies suggest Ozempic is generally more effective, but phentermine may be a good option in some cases.
So, how else do they compare? Keep reading for a breakdown of Ozempic vs. phentermine.
Phentermine vs. Ozempic at a glance
Ozempic is usually more effective than phentermine for weight loss, with people losing about 15 pounds in nine months at the highest dose of Ozempic.
Semaglutide (the active ingredient in Ozempic and Wegovy) also offers cardiovascular benefits. Phentermine has heart-related risks, which can be an important difference to consider.
But phentermine may be a better option in some cases, such as for those who prefer a pill over an injection or who want a more affordable drug.
Here's a quick overview of the two medications:
| Ozempic (semaglutide) | Phentermine |
|---|---|---|
Medication class | GLP-1 receptor agonist | Sympathomimetic |
FDA-approved for weight loss? | No, used off-label | Yes |
How it works | Mimics a gut hormone that lowers blood sugar levels, reduces appetite, slows digestion | Mild stimulant that suppresses appetite by boosting certain brain chemicals, also increases how much energy you use |
FDA-approved uses | Control blood sugar in adults with type 2 diabetes, along with diet and exercise To lower the risk of heart attack, stroke, and death in adults with both type 2 diabetes and heart disease To reduce the risk of worsening kidney problems in adults with type 2 diabetes and chronic kidney disease Off-label: weight management | Short-term weight management in people with a BMI of 30 or above, or a BMI of 27 or above, along with other risk factors, with diet and exercise Off-label: long-term weight management |
Form | Injection | Oral tablet, capsule, or disintegrating tablet |
How long to take it | Can be taken long-term | Up to 12 weeks |
Typical dose | Once weekly injection, with a starting dose of 0.25 mg and a maximum dose of 2 mg | 15 mg, 30 mg, or 37.5 mg daily, or low-dose version of 8 mg three times daily |
Effectiveness for weight loss | Very effective — with an average weight loss of 7%-15% long-term, depending on dose | Less effective — with an average weight loss of 5%-10% short term |
Common side effects | Gastrointestinal (GI) symptoms, such as nausea, vomiting, diarrhea, stomach pain | Increased blood pressure, heart rate, insomnia, restlessness, dry mouth, diarrhea, constipation |
Key risks | Risks for pancreatitis, kidney and gallbladder problems, low blood sugar, severe GI symptoms | Small potential for abuse and dependence, potential for worsening heart problems |
Cost, without insurance | About $1,000 monthly | As low as $10 monthly |
Key differences between Ozempic and phentermine
Ozempic is an injection, while phentermine is a pill.
Ozempic is taken weekly; phentermine is taken daily.
Ozempic is a GLP-1 agonist, and phentermine is a stimulant.
Ozempic is typically longer-term, and phentermine is usually short-term.
Ozempic can be used off-label for weight loss; phentermine is approved for weight loss.
Ozempic can help you lose a higher amount of weight compared to phentermine.
Ozempic can cause digestive issues; phentermine can cause heart and nervous system issues.
Ozempic is a brand-name drug that can be costly, while phentermine is a generic medication, which means it’s typically lower in price.
Ozempic is not habit-forming; phentermine carries a low risk of abuse and dependence and, as such, is a Schedule IV controlled substance.
Ozempic vs. phentermine side effects
Since Ozempic and phentermine belong to different drug classes and work in distinct ways, it’s not surprising that their possible side effects differ.
Side effect | Ozempic (semaglutide) | Phentermine |
|---|---|---|
Stomach Pain | ✅ | ❌ |
Nausea | ✅ | ✅ |
Diarrhea | ✅ | ✅ |
Constipation | ✅ | ✅ |
Trouble sleeping | ❌ | ✅ |
Restlessness, shakiness | ❌ | ✅ |
Fatigue | ✅ | ❌ |
Dry mouth | ❌ | ✅ |
Faster heart rate | ✅ | ✅ |
Headache | ❌ | ✅ |
When used incorrectly, both Ozempic and phentermine can potentially be dangerous for your health. It’s important to take only the dose prescribed by your healthcare provider, so they can monitor you for some of the more serious complications.
Ozempic can cause kidney and gallbladder concerns, dehydration, low blood sugar (if taken with certain diabetes medications), pancreatitis, and severe stomach problems. There have also been reports of pulmonary aspiration (stomach contents entering the lungs) during surgery requiring sedation in people taking Ozempic.
Phentermine is a stimulant and is considered a controlled substance. It can lead to dependence and abuse, especially in higher doses. There is also a risk of developing heart problems like heart valve disease and high blood pressure in the lungs, known as pulmonary hypertension.
Other side effects are possible with either medication. Reach out to your healthcare provider or seek medical care if side effects don’t go away or seem severe.
Ozempic side effects
The most common side effects of Ozempic include:
Vomiting
Stomach pain
You may notice a theme here — these common side effects are all related to gastrointestinal issues. This makes sense, since Ozempic affects how we digest food.
Phentermine side effects
While Ozempic’s side effects primarily relate to its impact on digestion, phentermine’s side effects are largely related to its being a mild stimulant. Possible side effects of phentermine include:
Nervousness and excitability
Headache
Dry mouth or thirst
Dizziness
Fast heart rate
Increase in blood pressure
Palpitations
Nausea
Constipation
Changes in libido
These effects are similar to some of the effects of other stimulants, such as amphetamines (e.g. Adderall).
Ozempic vs. phentermine: what the science says
Ozempic can help you lose more weight than phentermine, based on results from separate studies.
Ozempic and phentermine haven’t been directly compared in head-to-head clinical trials. But when used along with a nutritious diet and regular exercise, either one can be quite effective for weight loss. Everyone is different, so the amount of weight loss will vary from person to person.
Ozempic’s effectiveness:
In a trial for type 2 diabetes, people taking 1 mg of Ozempic lost about 13 pounds after about nine months, while those taking 2 mg lost about 15 pounds in the same timeframe.
In studies for type 2 diabetes, people taking 0.5 mg or 1 mg of Ozempic lost 5%–7% of their starting body weight after 7–12 months.
In a trial for obesity, people taking 2.4 mg of semaglutide (the highest dose of Wegovy) lost about 15% on average over 68 weeks. The participants in this study did not have diabetes.
Phentermine’s effectiveness:
Weight loss with phentermine largely depends on the dose and the duration of use.
It’s only FDA-approved for short-term use, but longer use may work better.
In an analysis of six studies lasting 2–24 weeks, people taking phentermine lost about 8 pounds more than those on placebo. On average, people taking the drug lost about 14 pounds.
One study found taking phentermine led participants to lose at least 5% of their body weight loss after six months.
To put it in perspective, weight loss medications are generally considered successful if you lose more than 5% of your body weight after 12 weeks of treatment with the recommended dosage.
So really, either medication can be effective for weight loss.
Ozempic typically leads to a more substantial reduction in body weight.
Phentermine may help people lose weight more quickly (within a few weeks).
Phentermine is an older medication. It was FDA-approved for weight loss in 1959 for short-term use, based on less clinical data than what’s required for newer weight loss drugs. It may also stop working after a while — some people can develop a tolerance to its appetite-suppressing effects.
Despite its short-term approval, there have been some longer-term studies. Recent observational research of nearly 14,000 adults found the following results:
People who used phentermine for more than a year lost significantly more weight — about 7.4% more at two years — than those who used it for 3 months or less.
Those who took phentermine long-term did not have an increased risk of heart problems or death.
These results and other evidence suggest that long-term phentermine may be safe in low-risk individuals. As such, some healthcare providers may prescribe it long-term or on an intermittent schedule (e.g. several weeks “on” then several weeks “off”). But it depends on their professional judgement and your medical history.
Ozempic vs. phentermine cost
Ozempic tends to cost more than phentermine. This is because:
Ozempic is only available as a brand-name medication, while phentermine comes in a generic version.
Ozempic is given by injection, and phentermine is available as a tablet
Insurance likely won’t cover Ozempic for weight loss alone because it’s not specifically FDA-approved for this use.
Weight loss medications are rarely covered by insurance.
Without insurance, phentermine can cost less than $10 a month (depending on the pharmacy).
Ozempic, on the other hand, can cost about $1,000 a month out-of-pocket.
But if you take Ozempic for type 2 diabetes, your insurance may cover it. You can ask your healthcare provider for Wegovy instead, which contains the same active ingredient as Ozempic but is FDA-approved for weight loss and has a higher maximum dose.
The Ro Body membership includes insurance verification to take the stress out of navigating insurance coverage. The manufacturer of Ozempic, Novo Nordisk, also offers a savings program if you’re eligible.
Who shouldn’t take Ozempic or phentermine?
Ozempic and phentermine are safe for most people, but these medications aren’t right for everyone.
Who shouldn’t take Ozempic?
Don’t take Ozempic if you are nursing, pregnant, planning to become pregnant, or if you have:
A certain type of thyroid cancer, called medullary thyroid carcinoma (MTC) or a family history of MTC
Multiple endocrine neoplasia type 2 (MEN 2), a disorder that causes tumors in the thyroid and other glands
If you have certain health conditions, Ozempic can make them worse. Your healthcare provider might recommend extra monitoring or using a different medication altogether if you have:
Pancreatitis
Diabetic retinopathy
Gallbladder disease
Digestive problems, such as severe gastroparesis
Upcoming surgery that requires sedation
Ozempic may also lead to hypoglycemia (low blood sugar) when combined with insulin or certain diabetes pills (such as glimepiride).
Who shouldn’t take phentermine?
If you are pregnant, nursing, or have a history of any of the following, you shouldn’t take phentermine:
Heart disease (including high blood pressure, coronary artery disease, heart attack or stroke, or congestive heart failure)
Hyperthyroidism
Glaucoma
Drug abuse or substance use disorder
Agitation (a possible symptom of some mental health conditions)
You shouldn’t use phentermine with alcohol. Don’t use phentermine while taking or within 14 days of stopping an MAOI (monoamine oxidase inhibitor) because it can cause dangerously high blood pressure.
Is it safe to take Ozempic and phentermine together?
It’s possible to take Ozempic and phentermine together if your healthcare provider prescribes both. It’s unknown if using the two together is safe or leads to more weight loss, since the combination hasn’t been studied.
Ozempic and phentermine aren’t known to interact with each other. But according to the prescribing information for phentermine, it’s not recommended to take it with other weight loss medications.
But your healthcare provider might prescribe both if that’s your best option. There are a few things to keep in mind.
You’ll likely start on one medication initially. Since semaglutide works well for weight loss, your healthcare provider may not add phentermine. Instead, you may have your semaglutide dose increased.
You might add another if needed. If you aren’t seeing the weight loss you need, your healthcare provider might add the second medication to potentially get better results.
But taking the medications together can increase side effects. The more medications you take, the more chances there are for side effects. You may tolerate both medications just fine, but let your provider know if you’re experiencing uncomfortable side effects.
Alternatives to Ozempic and phentermine
There are many other medications that can help with weight management, all with their different effectiveness, side effects, and costs.
Some of the most common weight loss alternatives to Ozempic and phentermine include:
Wegovy (semaglutide): Unlike Ozempic, Wegovy is FDA-approved for weight loss and is a GLP-1 medication injected weekly.
Zepbound (tirzepatide): A GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), Zepbound is FDA-approved for weight loss and works similarly to other GLP-1s.
Saxenda (liraglutide): A GLP-1 receptor agonist, it’s FDA-approved for weight loss, given as a daily injection.
Qsymia (phentermine/topiramate): A combination medication taken as a daily capsule, Qsymia works better than either medication alone to control overeating and reduce appetite. Unlike phentermine alone, Qsymia is FDA-approved for long-term weight management.
Contrave (naltrexone/bupropion): A combination medication, Contrave is a daily tablet approved for weight management to decrease cravings and appetite. Side effects can include nausea, constipation, and headache.
Orlistat (Xenical, Alli): Available as both a prescription (Xenical) and over-the-counter formulation (Alli), orlistat is a medication that blocks fats you eat from being absorbed. It’s a capsule taken three times a day with meals. It can cause fatty stools and diarrhea.
Wegovy, Saxenda, and Zepbound are GLP-1 medications that tend to cause more weight loss than oral weight loss medications, including Qsymia, Contrave, and orlistat. But the flip side is they tend to be higher in cost.
Bottom line
Both Ozempic and phentermine can be used for weight management. But they differ in their FDA-approved uses, how they work, side effects, effectiveness, and more. Here’s what to keep in mind:
Ozempic is a weekly injection that’s FDA-approved for people with type 2 diabetes, but it can also reduce your appetite and promote significant weight loss. Because of this, Ozempic is often prescribed off-label for weight loss.
Phentermine is an oral pill that can suppress appetite, but it isn’t safe for some people. It’s a mild stimulant that can affect heart rate and blood pressure. It’s specifically approved for short-term weight loss.
Other key differences between Ozempic and phentermine include their overall effectiveness, their side effect profiles, and their cost. Ozempic typically leads to greater weight loss, can lead to gastrointestinal side effects, and tends to be more expensive compared to phentermine.
Frequently asked questions (FAQs)
What is Ozempic?
Ozempic (semaglutide) is part of a class of medications called GLP-1s, which stands for glucagon-like peptide-1 receptor agonists. It helps lower blood sugar levels in people with type 2 diabetes, along with diet and exercise.
What is phentermine?
Phentermine is FDA-approved as a short-term weight-loss medication. It’s a mild stimulant similar to amphetamines. This weight-loss pill has been around since 1959. Some studies show it can be safe and effective for long-term use for many people.
Is Ozempic approved for weight loss?
No, Ozempic is not FDA-approved for weight loss. But healthcare providers can prescribe Ozempic off-label if it’s the best treatment for you. However, semaglutide, the active ingredient in Ozempic, can be prescribed for weight loss under the brand name Wegovy.
How does phentermine help with weight loss?
Phentermine is a mild stimulant that works for weight loss by suppressing appetite. It’s meant to be used short-term, up to 12 weeks. But it can be used off-label for longer than three months, or with an intermittent schedule (e.g. four weeks “on” then four weeks “off”), only under the guidance of your prescriber.
Does phentermine burn fat or suppress appetite?
Phentermine suppresses appetite, rather than burning fat directly. It works for weight loss by releasing the neurotransmitter norepinephrine in the area of the brain that controls appetite. This causes you to feel less hungry. It also boosts how many calories you burn at rest. And by getting regular exercise, including resistance training, you’ll likely see fat loss.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
Saxenda Important Safety Information: Read more about serious warnings and safety info.
References
Apovian, C. M., Aronne, L. J., Bessesen, D. H., et al. (2015). Pharmacological management of obesity: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 100(2), 342-362. doi: 10.1210/jc.2014-3415. Retrieved from https://academic.oup.com/jcem/article/100/2/342/2813109
Bansal, A. B., Patel, P., & Al Khalili, Y. (2024). Orlistat. StatPearls. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK542202/
DailyMed. (2024). Prescribing information: Phentermine hydrochloride capsule, for oral use [15 mg, 30 mg]. Retrieved from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e4508aa9-1e7a-4af7-829e-5fa353c92f5e&type=display
DailyMed. (2025). Prescribing information: Phentermine hydrochloride tablet [8 mg]. Retrieved from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d70f0be3-fcc7-4a1d-9a82-bb1bb21a1528&type=display
Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet (London, England), 397(10278), 971–984. doi: 10.1016/S0140-6736(21)00213-0. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33667417/
Frías, J. P., Auerbach, P., Bajaj, H. S., et al. (2021). Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): A double-blind, randomised, phase 3B trial. The Lancet: Diabetes & Endocrinology. Retrieved from https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00174-1/
Gomez, G. & Stanford, F. C. (2018). US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity. International Journal of Obesity, 42(3), 495–500. doi: 10.1038/ijo.2017.287. Retrieved from https://pubmed.ncbi.nlm.nih.gov/29151591/
Jordan, J., Astrup, A., Engeli, S., et al. (2014). Cardiovascular effects of phentermine and topiramate: A new drug combination for the treatment of obesity. Journal of Hypertension, 32(6), 1178. doi: 10.1097/HJH.0000000000000145. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC4011567/
Kang, J. G., Park, C. Y., Kang, J. H., et al. W. (2010). Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. Diabetes, Obesity & Metabolism, 12(10), 876–882. doi: 10.1111/j.1463-1326.2010.01242.x https://pubmed.ncbi.nlm.nih.gov/2092004
Kommu, S. & Whitfield, P. (2024). Semaglutide. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK603723/
Lewis, K. H., Fischer, H., Ard, J., et al. (2019). Safety and effectiveness of longer-term phentermine use: clinical outcomes from an electronic health record cohort. Obesity, 27(4), 591–602. doi: 10.1002/oby.22430. Retrieved from https://onlinelibrary.wiley.com/doi/10.1002/oby.22430
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. (2020). Phentermine. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK547916/
Márquez-Cruz, M., Kammar-García, A., Huerta-Cruz, J. C., et al. (2021). Three- and six-month efficacy and safety of phentermine in a Mexican obese population. International Journal of Clinical Pharmacology and Therapeutics, 59(8), 539. doi: 10.5414/CP203943. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8295716/
Miller, C. C., Pandey, A., & Litwin, S. E. (2025). Safety and Efficacy of Phentermine and Topiramate for Weight Loss in Obesity-Related HFpEF. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2025.08.027. doi: 10.1016/j.cardfail.2025.08.027. Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S1071916425004622
Moll, H., Frey, E., & Gerber, P., et al. (2024). GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit–harm modelling study. eClinicalMedicine, 73, 102661. doi: 10.1016/j.eclinm.2024.00240. Retrieved from https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00240-2/fulltext
Nuako, A., Tu, L., Campoverde Reyes, K. J., et al. (2023). Pharmacologic Treatment of Obesity in Reproductive Aged Women. Current Obstetrics and Gynecology Reports, 12(2), 138. doi: 10.1007/s13669-023-00350-1. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10328448/
NovoCare. (2022). Request or activate your Ozempic® savings card. Retrieved from https://www.novocare.com/content/novocare/en/ozempic/savings-card.html
Patel, J. P., Hardaswani, D., Patel, J., et al. (2025). Comparative Effectiveness of Semaglutide, Liraglutide, Orlistat, and Phentermine for Weight Loss in Obese Individuals: A Systematic Review. Cureus, 17(3), e80321. doi: 10.7759/cureus.80321 Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11979670/
Rocha-González, H. I., De la Cruz-Álvarez, L. E., Kammar-García, A., et al. (2021). Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months. Journal of Personalized Medicine, 11(12), 1354. doi: 10.3390/jpm11121354. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8707701/
Røder, M. E. (2019). Clinical potential of treatment with semaglutide in type 2 diabetes patients. Drugs in Context, 8, 212585. doi: 10.7573/dic.212585 Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6905643/
SingleCare. (n.d.). Phentermine HCL Coupons & Prices. Retrieved from https://www.singlecare.com/prescription/phentermine-hcl
U.S. Food & Drug Administration (FDA). (2025). Highlights of Prescribing Information: Ozempic (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s035,209637s037lbl.pdf
U.S. Food and Drug Administration (FDA-a). (2024). Highlights of Prescribing Information: Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/200063s022lbl.pdf
U.S. Food and Drug Administration (FDA). (2022). Highlights of Prescribing Information: PHENTERMINE hydrochloride capsules USP, for oral use. Retrieved from https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/129e781c-5366-4986-8e67-6b35fa4c3f39/spl-doc
U.S. Food and Drug Administration (FDA-b). (2024). Highlights of Prescribing Information: QSYMIA (phentermine and topiramate extended-release capsules), for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022580s029lbl.pdf
Yanovski, S. Z. & Yanovski, J. A. (2014). Long-term drug treatment for obesity: a systematic and clinical review. JAMA, 311(1), 74–86. doi: 10.1001/jama.2013.281361 Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC3928674/
Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989–1002. doi: 10.1056/NEJMoa2032183. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33567185/














